|
Thrombolysis
Citations 81-90 of 134 total displayed.
|
Past content
(since Feb 1998):
|
- Original Contributions
Racial and Ethnic Differences in Time to Acute Reperfusion Therapy for Patients Hospitalized With Myocardial Infarction
- Elizabeth H. Bradley; Jeph Herrin; Yongfei Wang; Robert L. McNamara; Tashonna R. Webster; David J. Magid; Martha Blaney; Eric D. Peterson; John G. Canto; Charles V. Pollack, Jr; Harlan M. Krumholz
JAMA 2004; 292: 1563-1572.
[Abstract]
[Full text]
[PDF]
- Editorials
Do Transfusions Get to the Heart of the Matter?
- Paul C. Hébert; Dean A. Fergusson
JAMA 2004; 292: 1610-1612.
[Extract]
[Full text]
[PDF]
- Editorials
Measuring Race and Ethnicity: Why and How?
- Margaret A. Winker
JAMA 2004; 292: 1612-1614.
[Extract]
[Full text]
[PDF]
- Letters
Fractionating Heparin—Reply
- Pranab Das; David J. Moliterno
JAMA 2004; 292: 1427-b-1428-b.
[Extract]
[Full text]
[PDF]
- Letters
Fractionating Heparin
- Ehud Arbit
JAMA 2004; 292: 1427-a.
[Extract]
[Full text]
[PDF]
- Medical News & Perspectives
Study Reveals Ginseng Supplements May Hamper Effects of Anticlotting Drug
- Mike Mitka
JAMA 2004; 292: 674.
[Extract]
[Full text]
[PDF]
- Original Contributions
Long-term Efficacy of Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade vs Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Revascularization: REPLACE-2 Randomized Trial
- A. Michael Lincoff; Neal S. Kleiman; Dean J. Kereiakes; Frederick Feit; John A. Bittl; J. Daniel Jackman; Ian J. Sarembock; David J. Cohen; Douglas Spriggs; Ramin Ebrahimi; Gadi Keren; Jeffrey Carr; Eric A. Cohen; Amadeo Betriu; Walter Desmet; Wolfgang Rutsch; Robert G. Wilcox; Pim J. de Feyter; Alec Vahanian; Eric J. Topol; for the REPLACE-2 Investigators
JAMA 2004; 292: 696-703.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Enoxaparin vs Unfractionated Heparin in High-Risk Patients With Non–ST-Segment Elevation Acute Coronary Syndromes Managed With an Intended Early Invasive Strategy: Primary Results of the SYNERGY Randomized Trial
- SYNERGY Trial Investigators
JAMA 2004; 292: 45-54.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Safety and Efficacy of Enoxaparin vs Unfractionated Heparin in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes Who Receive Tirofiban and Aspirin: A Randomized Controlled Trial
- Michael A. Blazing; James A. de Lemos; Harvey D. White; Keith A. A. Fox; Freek W. A. Verheugt; Diego Ardissino; Peter M. DiBattiste; Joanne Palmisano; David W. Bilheimer; Steven M. Snapinn; Karen E. Ramsey; Laura H. Gardner; Vic Hasselblad; Marc A. Pfeffer; Eldrin F. Lewis; Eugene Braunwald; Robert M. Califf; for the A to Z Investigators
JAMA 2004; 292: 55-64.
[Abstract]
[Full text]
[PDF]
- Reviews
Efficacy and Bleeding Complications Among Patients Randomized to Enoxaparin or Unfractionated Heparin for Antithrombin Therapy in Non–ST-Segment Elevation Acute Coronary Syndromes: A Systematic Overview
- John L. Petersen; Kenneth W. Mahaffey; Vic Hasselblad; Elliott M. Antman; Marc Cohen; Shaun G. Goodman; Anatoly Langer; Michael A. Blazing; Anne Le-Moigne-Amrani; James A. de Lemos; Christopher C. Nessel; Robert A. Harrington; James J. Ferguson; Eugene Braunwald; Robert M. Califf
JAMA 2004; 292: 89-96.
[Abstract]
[Full text]
[PDF]
|
|
